Evidence mapPaperPMID 36364256Full record

ArticleMolecules (Basel, Switzerland)2022

Anti-Inflammatory, Antioxidative, and Nitric Oxide-Scavenging Activities of a Quercetin Nanosuspension with Polyethylene Glycol in LPS-Induced RAW 264.7 Macrophages.

Sang Gu Kang, Gi Baek Lee, Ramachandran Vinayagam, Geum Sook Do, Se Yong Oh, Su Jin Yang, Jun Bum Kwon, Mahendra Singh

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.7field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Salvimulticanol from3 Biotech · 2024
    Article
  16. Tart Cherry (Foods (Basel, Switzerland) · 2023
    Article
  17. Article
  18. Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Sang Gu KangDepartment of Biotechnology, Institute of Biotechnology, Life and Applied Sciences, Yeungnam University, Gyeongsan 38541, Korea.ORCID 0000-0002-5216-5494
Gi Baek LeeDepartment of Biotechnology, Institute of Biotechnology, Life and Applied Sciences, Yeungnam University, Gyeongsan 38541, Korea.
Ramachandran VinayagamDepartment of Biotechnology, Institute of Biotechnology, Life and Applied Sciences, Yeungnam University, Gyeongsan 38541, Korea.ORCID 0000-0003-3568-2358
Geum Sook DoDepartment of Biology, College of Natural Sciences, Kyungpook National University, Buk-gu, Daegu 41566, Korea.ORCID 0000-0001-8460-8926
Se Yong OhNova M Healthcare Co., Ltd., 16-53, Jisiksaneop 4-ro, Gyeongsan 38408, Korea.
Su Jin YangNova M Healthcare Co., Ltd., 16-53, Jisiksaneop 4-ro, Gyeongsan 38408, Korea.
Jun Bum KwonNova M Healthcare Co., Ltd., 16-53, Jisiksaneop 4-ro, Gyeongsan 38408, Korea.
Mahendra SinghDepartment of Biotechnology, Institute of Biotechnology, Life and Applied Sciences, Yeungnam University, Gyeongsan 38541, Korea.
Yeungnam University · KRKyungpook National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Quercetin (Qu) is a dietary antioxidant and a member of flavonoids in the plant polyphenol family. Qu has a high ability to scavenge reactive oxygen species (ROS) and reactive nitrogen species (RNS) molecules; hence, exhibiting beneficial effects in preventing obesity, diabetes, cancer, cardiovascular diseases, and inflammation. However, quercetin has low bioavailability due to poor water solubility, low absorption, and rapid excretion from the body. To address these issues, the usage of Qu nanosuspensions can improve physical stability, solubility, and pharmacokinetics. Therefore, we developed a Qu and polyethylene glycol nanosuspension (Qu-PEG NS) and confirmed its interaction by Fourier transform infrared analysis. Qu-PEG NS did not show cytotoxicity to HaCaT and RAW 264.7 cells. Furthermore, Qu-PEG NS effectively reduced the nitrogen oxide (NO) production in lipopolysaccharide (LPS)-induced inflammatory RAW 264.7 cells. Additionally, Qu-PEG NS effectively lowered the levels of COX-2, NF-κB p65, and IL-1β in the LPS-induced inflammatory RAW 264.7 cells. Specifically, Qu-PEG NS exhibited anti-inflammatory properties by scavenging the ROS and RNS and mediated the inhibition of NF-κB signaling pathways. In addition, Qu-PEG NS had a high antioxidant effect and antibacterial activity against

Indexed as

LipopolysaccharidesQuercetinAnimalsAnti-Bacterial AgentsAnti-Inflammatory AgentsAntioxidantsMacrophagesMiceNF-kappa BNitric OxidePolyethylene GlycolsRAW 264.7 CellsReactive Oxygen SpeciesAnti-Bacterial AgentsAnti-Inflammatory AgentsAntioxidantsLipopolysaccharidesNF-kappa BNitric OxidePolyethylene GlycolsQuercetinReactive Oxygen Speciesantioxidant propertiesflavonoidsLPS-induced inflammationnanosuspensionNO-scavenging activityquercetin

Identifiers

PMID36364256
PMCPMC9659305
OpenAlexW4308122980

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.